Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


MDMA consultant Kathy Means

This article was originally published in The Gray Sheet

Executive Summary

Consultant on reimbursement issues remains at Patton Boggs. "The Gray Sheet" characterized Means as a former senior public policy advisor for the Washington, D.C. law firm (1"The Gray Sheet" June 9, 2003, In Brief)...

You may also be interested in...

MDMA reimbursement advisory counsel

Kathy Means, formerly senior public policy advisor for law firm Patton Boggs, joins the trade association to advise on reimbursement issues. Means takes over for Dan Waldmann, who joined J&J as director of federal affairs & reimbursement for medical devices June 2 (1"The Gray Sheet" May 19, 2003, In Brief)...

Real World Data Failed To Impress Kaftrio’s European Reviewers

The European public assessment report for Kaftrio shows that EU regulators had concerns about whether Vertex’s triple drug combination for cystic fibrosis represented a new treatment paradigm.

Swissmedic Clears Up Confusion Over Validity Of GMP Certificates

Swissmedic says its good manufacturing practice certificates remain valid for longer than companies might assume. Separately, it is giving companies more time to conduct nitrosamine-related risk evaluations.




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts